ELV
Elevance Health Inc.
$394.69
+4.87
(+1.25%)
Mkt Cap
85.71B
Volume
582,827
52W Range
273.71-408
Sector
Healthcare
Beta
0.67
EPS (TTM)
23.51
P/E Ratio
16.79
Revenue (TTM)
200.41B
Rev Growth (5Y)
+10.3%
EPS Growth (5Y)
+6.7%
AlphaVal · Fair Value
$408.31
Fair Value · Mild
3.3% below fair value
AlphaQuality · Grade
B-
Stable Earnings Power
66.1 / 100 composite
Company Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199.12B | 176.81B | 171.34B | 156.59B | 138.64B | 121.87B | 104.21B | 92.11B | 90.04B | 84.98B | 79.24B | 73.92B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.10B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B | 2.56B | 2.57B |
| EPS | 25.18 | 25.81 | 25.38 | 24.56 | 25.25 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 |
| Free Cash Flow | 3.17B | 4.55B | 6.76B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.62B | N/A | N/A |
| FCF / Share | 14.31 | 19.55 | 29.03 | 30.20 | 29.85 | 38.54 | 19.51 | 10.30 | 13.26 | 9.94 | N/A | N/A |
| Operating CF | 4.29B | 5.81B | 8.06B | 8.40B | 8.36B | 10.69B | 6.06B | 3.83B | 4.18B | 3.20B | N/A | N/A |
| Total Assets | 121.49B | 116.89B | 108.93B | 102.75B | 97.46B | 88.28B | 78.25B | 72.47B | 71.46B | 66.39B | N/A | N/A |
| Total Debt | 33.23B | 32.70B | 26.65B | 25.80B | 24.89B | 21.84B | 21.21B | 19.21B | 19.93B | 15.73B | N/A | N/A |
| Cash & Equiv | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B | 5.74B | 4.94B | 3.93B | 3.61B | 4.08B | N/A | N/A |
| Book Value | 43.88B | 41.31B | 39.31B | 36.24B | 36.06B | 33.20B | 31.73B | 28.54B | 26.50B | 25.10B | N/A | N/A |
| Return on Equity | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.14 | 0.15 | 0.13 | 0.14 | 0.10 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B | 45.15B | 43.65B | 42.58B | 42.65B | 42.85B | 43.67B |
| Net Income | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B | 2.25B | 856.00M | 1.29B | 1.85B |
| EPS | 8.00 | 2.47 | 5.32 | 7.72 | 9.64 | 1.84 | 4.36 | 9.91 | 9.65 | 3.67 | 5.48 | 7.83 |
| Free Cash Flow | 4.10B | (209.00M) | 775.00M | 1.79B | 821.00M | 384.00M | 2.35B | 124.00M | 1.70B | (3.30B) | 2.29B | 1.60B |
| FCF / Share | 18.58 | -0.94 | 3.43 | 7.91 | 3.63 | 1.69 | 10.06 | 0.53 | 7.30 | -14.15 | 9.75 | 6.76 |
| Operating CF | 4.33B | 84.00M | 1.14B | 2.05B | 1.02B | 706.00M | 2.68B | 447.00M | 1.98B | (2.97B) | 2.61B | 1.95B |
| Total Assets | 125.83B | 121.49B | 122.75B | 121.94B | 119.72B | 116.89B | 116.53B | 112.99B | 111.89B | 108.93B | 110.48B | 109.17B |
| Total Debt | 31.84B | 33.23B | 32.10B | 30.19B | 30.00B | 32.70B | 27.15B | 27.69B | 26.45B | 26.65B | 26.41B | 26.74B |
| Cash & Equiv | 9.66B | 9.49B | 8.71B | 8.56B | 7.50B | 8.29B | 7.87B | 6.50B | 6.23B | 6.53B | 10.92B | 9.99B |
| Book Value | 43.90B | 43.88B | 43.95B | 43.72B | 42.50B | 41.31B | 43.77B | 42.19B | 40.61B | 39.31B | 38.42B | 38.20B |
| Return on Equity | 0.04 | 0.01 | 0.03 | 0.04 | 0.05 | 0.01 | 0.02 | 0.05 | 0.06 | 0.02 | 0.03 | 0.05 |
ELV News
Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue?
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
Is ELV Undervalued? DCF Says Worth $643
Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript
A Look at Elevance Health Inc (ELV) After 4.0% Gain -- GF Value $518.29 vs Price $393.30
Is ELV Undervalued? DCF Says Worth $643
Is ELV Undervalued? DCF Says Worth $643
Major health insurers show signs of recovery – but a key test looms
This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how
Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care